04 January 2021

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

04 January 2021 | n=28

  1. Budd A, Krentz HB, Rubin LH, Power C, et al.
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS 2020;Publ.

  2. Ngongo NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al.
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS 2020;Publ.

  3. Ngalamika O, Munsaka S, Lidenge S, West J, et al.
    Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-related, and Sociodemographic Predictors of Outcome.
    AIDS Res Hum Retroviruses 2021.

  4. Zhao R, Ding R, Zhang Q.
    What are the risk factors for surgical site infection in HIV positive patients receiving open reduction and internal fixation of traumatic limb fractures? A retrospective cohort study.
    AIDS Res Hum Retroviruses 2021.

  5. Al-Khouja A, Shieh EC, Fuchs EJ, Marzinke MA, et al.
    Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: a First-in-Human Study.
    AIDS Res Hum Retroviruses 2020.

  6. Guerriero KA, Murnane RD, Lewis TB, Brown B, et al.
    Recrudescence of Natural Coccidioidomycosis during Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus.
    AIDS Res Hum Retroviruses 2020.

  7. Montano-Castellon I, Zeballos D, Gutierrez-Peredo G, Netto EM, et al.
    "High prevalence of frailty and pre-frailty status in Brazilian patients living with HIV".
    AIDS Res Hum Retroviruses 2020.

  8. Granich R, Gupta S.
    European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.
    Clin Infect Dis 2020;71:2917-2919.

  9. Lee JS, Humes EA, Hogan BC, Buchacz K, et al.
    CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018.
    Clin Infect Dis 2020.

  10. Crowell TA, Ritz J, Coombs RW, Zheng L, et al.
    Novel Criteria for Diagnosing Acute and Early HIV Infection in a Multi-National Study of Early Antiretroviral Therapy Initiation.
    Clin Infect Dis 2020.

  11. Das S, Allston A, Opoku J, Kharfen M, et al.
    A spatial approach for Ending the HIV Epidemic for the United States - A DC Model.
    Clin Infect Dis 2020.

  12. Boey L, Curinckx A, Roelants M, Derdelinckx I, et al.
    Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults.
    Clin Infect Dis 2020.

  13. Tack I, Dumicho A, Ohler L, Shigayeva A, et al.
    Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
    Clin Infect Dis 2020.

  14. Christopoulos KA, Neilands TB, Koester KA, Sauceda JA, et al.
    The HIV Index: Using a Patient-Reported Outcome on Engagement in HIV Care to Explain Sub-Optimal Retention in Care and Virologic Control.
    Clin Infect Dis 2020.

  15. Greenberg L, Ryom L, Neesgaard B, Wandeler G, et al.
    Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV.
    Clin Infect Dis 2020.

  16. Whitney BM, Srinivasan S, Tapia K, Muriuki EM, et al.
    Influence of intramuscular depot-medroxyprogesterone acetate initiation on vaginal microbiota in the postpartum period.
    Clin Infect Dis 2020.

  17. Castillo-Mancilla JR.
    Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure.
    Clin Infect Dis 2020;70:2152-2154.

  18. Rajasingham R, Boulware DR.
    Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?
    Clin Infect Dis 2020;70:1691-1694.

  19. Jankowski CM, Wilson MP, MaWhinney S, Reusch J, et al.
    Blunted muscle mitochondrial responses to exercise training in older adults with HIV.
    J Infect Dis 2020.

  20. Kroeze S, Rossouw TM, Steel HC, Wit FW, et al.
    Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
    J Infect Dis 2020.

  21. Rawat P, Brummel SS, Singh KK, Kim J, et al.
    Genomics Links Inflammation with Neurocognitive Impairment in Children Living with Human Immunodeficiency Virus type-1.
    J Infect Dis 2020.

  22. Sortino O, Dias J, Anderson M, Laidlaw E, et al.
    Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.
    J Infect Dis 2020.

  23. Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, et al.
    Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.
    J Infect Dis 2020.

  24. Dubey RC, Alam NB, Gaur R.
    miR-150-mediated increase in glucose uptake in HIV-infected cells.
    J Med Virol 2020.

  25. Zhang Y, Murakoshi H, Chikata T, Akahoshi T, et al.
    Effect of difference in consensus sequence between HIV-1 subtype A/E and subtype B viruses on elicitation of Gag-specific CD8(+) T cells and accumulation of HLA-associated escape mutations.
    J Virol 2020.

  26. Sanz M, Madrid-Elena N, Serrano-Villar S, Vallejo A, et al.
    Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.
    J Virol 2020.

  27. Gaebler C, Falcinelli SD, Stoffel E, Read J, et al.
    Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA.
    J Virol 2020.

  28. Gold D.
    Food banks and infant formula: formula is critical for mothers with HIV.
    BMJ 2020;371:m4923.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

25 January 2021

18 January 2021

11 January 2021

04 January 2021

28 December 2020


04 January 2021

Multidisciplinary Journal Club

  1. Overton ET, Richmond G, Rizzardini G, Jaeger H, et al.
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet. 2021;396:1994-2005.

  2. Cavallieri F, Fraix V, Bove F, Mulas D, et al.
    Predictors of long-term outcome of subthalamic stimulation in Parkinson disease.
    Ann Neurol. 2020 Dec 21. doi: 10.1002/ana.25994.

  3. Rajan KB, Aggarwal NT, McAninch EA, Weuve J, et al.
    Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study.
    Ann Neurol. 2020;88:1065-1076.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016